SOMAXON PHARMACEUTICALS, INC. Operating Cash Flow
SOMAXON PHARMACEUTICALS, INC. reported Operating Cash Flow of -$5.56 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-11-01
- SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2012-09-30 was -$1.98M.
- SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was -$670.00K.
- SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was -$2.91M.
- SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was -$9.26M.
- SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2011 was -$49.49M.
- SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2010 was -$29.70M.
- SOMAXON PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2009 was -$9.56M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$2.65M derived: sum of 2 quarters · filed 2012-11-01 | -$5.56M 10-Q · filed 2012-11-01 | -$14.82M derived: sum of 4 quarters · filed 2012-11-01 |
| 2012-06-30 | -$670.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$3.58M 10-Q · filed 2012-08-08 | -$12.85M derived: sum of 3 quarters · filed 2012-08-08 | -$24.67M derived: sum of 4 quarters · filed 2012-11-01 |
| 2012-03-31 | -$2.91M 10-Q · filed 2012-05-10 | -$12.18M derived: sum of 2 quarters · filed 2012-05-10 | -$24.00M derived: sum of 3 quarters · filed 2012-11-01 | -$41.16M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-12-31 | -$9.26M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | -$21.09M derived: sum of 2 quarters · filed 2012-11-01 | -$38.24M derived: sum of 3 quarters · filed 2012-11-01 | -$49.49M 10-K · filed 2012-03-09 |
| 2011-09-30 | -$11.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$28.98M derived: sum of 2 quarters · filed 2012-11-01 | -$40.23M 10-Q · filed 2012-11-01 | -$51.88M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-06-30 | -$17.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$28.40M 10-Q · filed 2012-08-08 | -$40.05M derived: sum of 3 quarters · filed 2012-08-08 | -$52.45M derived: sum of 4 quarters · filed 2012-08-08 |
| 2011-03-31 | -$11.25M 10-Q · filed 2012-05-10 | -$22.90M derived: sum of 2 quarters · filed 2012-05-10 | -$35.29M derived: sum of 3 quarters · filed 2012-05-10 | |
| 2010-12-31 | -$11.65M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | -$24.05M derived: sum of 2 quarters · filed 2012-03-09 | -$29.70M 10-K · filed 2012-03-09 | |
| 2010-09-30 | -$12.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$18.05M 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | -$5.65M 10-Q · filed 2011-08-03 | |||
| 2009-12-31 | -$9.56M 10-K · filed 2012-03-09 |